Search the Newsreel

Danaher earnings up next: Can bioprocessing recovery continue?

Danaher Corporation is set to report Q2 earnings, with investors keenly watching for sustained bioprocessing recovery and the integration progress of its $9.9 billion Masimo acquisition. Analysts anticipate modest year-over-year growth but a sequential decline in profitability, while maintain a bullish "Strong Buy" rating …

Andhra Paper profit falls 79% to ₹18.62 crore in FY26

Andhra Paper files BRSR for FY 2025-26

Danaher (DHR) Q2 Earnings Report Preview: What To Look For

Danaher (DHR) Q2 Earnings Report Preview: What To Look For Diversified science and technology company Danaher (NYSE:DHR) will be reporting results this Tuesday before market hours. Here's what you need to know. Danaher missed analysts' revenue expectations last quarter, reporting revenues of $5.95 billion, …

Danaher stock remains supported by earnings and margins

Danaher Corporation's stock is currently priced at $196.74, underpinned by strong financial results from 2025, including $23.9 billion in revenue and an adjusted diluted EPS of $7.66. Despite a 5.8% decline in core revenue, the company maintained a robust 27.3% adjusted operating margin, highlighting …

Danaher (DHR) Is Expanding Diagnostics With A StatLab Medical Products Deal

Danaher, through its Leica Biosystems unit, is set to acquire StatLab Medical Products, enhancing its diagnostics and anatomical pathology offerings with more consumables and instruments. This strategic move aims to strengthen Danaher's recurring revenue streams and better position it within the global anatomical pathology …

Form 4 Danaher Corporation For: 16 July By Investing.com

This article reports on a Form 4 filing for Danaher Corporation (DHR) dated July 16, as published by Investing.com. It mentions DHR's stock performance, showing a 2.10% increase. The content provided is minimal, primarily serving as a placeholder for a financial filing announcement.

Danaher Corp (NYSE: DHR) VP details 60-share stock tax withholding

Danaher Corp's VP and Chief Accounting Officer, Christopher Bouda, reported a tax-withholding disposition of 60 shares of common stock at $200.79 per share to cover tax liabilities. After this transaction, Bouda directly holds 9,107 shares and indirectly holds 679.101 shares through a 401(k) plan. …

Danaher (NYSE: DHR) director exercises options, 3,298 shares acquired

Danaher director Elias A. Zerhouni exercised options to acquire 3,298 common shares at an exercise price of $71.88, with 1,181 shares subsequently used for tax withholding at $200.79 per share. Following these transactions, Zerhouni directly holds 46,484.282 shares and indirectly holds 7,500 shares through …

Danaher Gears Up to Post Q2 Earnings: Is a Beat in the Offing?

Danaher Corporation (DHR) is set to release its Q2 2026 earnings, with analysts projecting a revenue increase of 2.6% to $6.09 billion and earnings per share of $1.84, a 2.2% rise. The company has consistently beaten Zacks Consensus Estimates in the past, and its …

Countdown to Danaher (DHR) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Danaher (DHR) is projected to report Q2 earnings of $1.84 per share and revenues of $6.09 billion, representing year-over-year increases of 2.2% and 2.6% respectively. Analysts have made slight downward adjustments to the EPS estimate, which can influence investor actions. Beyond overall revenue and …

Leica Biosystems acquires StatLab to strengthen anatomic pathology and AI-enabled cancer diagnostics

Leica Biosystems, a subsidiary of Danaher, announced its acquisition of StatLab Medical Products from Linden Capital Partners and Audax Private Equity. This deal will integrate StatLab's 50-year histology workflow portfolio with Leica Biosystems' computational pathology platform, aiming to enhance laboratory standardization for AI-driven cancer …

Liquidity Mapping Around (DHR) Price Events

This article analyzes Danaher Corporation (NYSE: DHR) using AI models to provide trading strategies and multi-timeframe signal analysis. It indicates strong near and mid-term sentiment but a weak long-term outlook, highlighting a significant risk-reward short setup. The analysis includes specific entry, target, and stop-loss …

Danaher stock holds steady as diversified life sciences portfolio underpins long-term growth

Danaher Corp. (ISIN US2358511028) is highlighted as a global life sciences and diagnostics supplier, appealing to long-term investors due to its diversified portfolio and recurring revenue streams. The company's focus on essential laboratory and clinical workflows, alongside strategic acquisitions and continuous improvement, underpins its …

Danaher’s Leica Biosystems to Acquire StatLab

Danaher's Leica Biosystems is set to acquire StatLab, a privately-held manufacturer of anatomical pathology products. StatLab, with over 50 years of history, offers products for pre-analytical and analytical histology, complementing Leica Biosystems' focus on cancer diagnostics. The acquisition aims to advance cancer diagnostics, improve …

Danaher stock may move 4.9% on July 21 earnings report By Investing.com

Danaher Corp. (DHR) shares are expected to move 4.9% following its earnings report on July 21, based on options data. The stock has historically surpassed this options-implied movement in three of its last eight earnings announcements. Notably, on October 21, 2025, shares increased by …

EMUDHRA Forecast — Price Target — Prediction for 2027

Dhruv Consultancy Services Ltd acquires 55% stake in Verul Drivehub

Dhruv Consultancy wins Rs 30.14 lakh UP bridge project

Dhruv Consultancy wins ₹19.34 crore railway project

Dhruv Consultancy Secures ₹19.34 Crore Infrastructure Contract as MCap Reaches ₹50 Crore

Statutory Profit Doesn't Reflect How Good Andhra Sugars' (NSE:ANDHRSUGAR) Earnings Are

Dhruv Consultancy Bags ₹8.34 Crore MPRDC Highway Order

Dhruv Consultancy wins Rs 8.33 crore MPRDC contract

Sagar Cements to merge Andhra Cements to boost efficiency

Andhra Paper Faces Continued Disruption at Kadiam Unit Post-Lockout

Dhruv Consultancy reports FY26 net loss on project revisions

Andhra Cements opens special window for share transfer

Andhra Cements FY26 revenue surges 61.5% to ₹44,249 crore

Andhra Sugars reports standalone net profit to Rs 83.67 crore in 2025-26

Andhra Sugars suspends crushing at two units for 2026-27 season

Andhra Sugars reports FY26 profit surge, declares dividend

Dhruv Consultancy wins ₹8.01 crore NHAI order

Andhra Paper Reports 29% Revenue Jump to ₹5.3B as Margins Compress to 4.76% in Q4

Andhra Paper Q4 & FY26 Results: Revenue Rises, Annual Profit Declines; MD Re-Appointed

eMudhra Q4 FY26 Earnings Call: FY27 Guidance, US Growth & Strategic Outlook